Patent · US Active

In vivo production of proteins

US9572896B2 · kind B2 · utility

65Cited by

1References

11Claims

0Family size

Assignee

ModernaTX, Inc. · US

Inventors

Stephane Bancel · Cambridge, US
Tirtha Chakraborty · Medford, US
Antonin de Fougerolles · Waterloo, BE
Sayda M. Elbashir · Cambridge, US
Matthias John · Hallstadt, DE
Atanu Roy · Stoneham, US
Susan Whoriskey · Belmont, US
Kristy M. Wood · Wellesley, US
Paul Hatala · Boston, US
Jason P. Schrum · Philadelphia, US
Kenechi Ejebe · New York, US
Jeff Lynn Ellsworth · Lexington, US
Justin Guild · Framingham, US

Key dates

Filing date	Aug 12, 2015
Grant date	Feb 21, 2017
Priority date	—
Expiry date	Aug 12, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.